IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB)

Historical Holders from Q3 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
INAB on Nasdaq
Shares outstanding
9,783,925
Price per share
$2.17
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
286,664
Holdings value
$622,061
Share change
0
Number of holders
1
Price from insider filings
$0.1844
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ho William Tai-Wei 5.6% $737,784 4,098,800 William Tai-Wei Ho 31 Dec 2024
BIOS Fund II, LP 4% -60% $849,245 -$18,941,314 391,357 -96% BIOS Capital Management, LP 22 Dec 2025
HIRSCHMAN ORIN 4.4% -46% $17,987 -$725,036 149,895 -98% Orin Hirschman 30 Jun 2025
Alyeska Investment Group, L.P. 2.6% -73% $186,054 -$14,947,795 89,021 -99% Alyeska Investment Group, L.P. 30 Jun 2025

Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 286,664 $622,061 $2.17 1
2025 Q2 286,664 $599,128 -$19,546,322 $2.09 1
2025 Q1 21,678,562 $3,599,041 -$1,466,430 $0.1660 28
2024 Q4 30,029,181 $7,723,566 +$3,536,863 $0.2572 25
2024 Q3 7,625,615 $2,058,934 -$108,305 $0.2700 25
2024 Q2 7,101,123 $6,010,532 -$1,014,975 $0.8465 24
2024 Q1 8,640,434 $10,226,862 +$62,538 $1.18 31
2023 Q4 8,582,106 $11,395,569 +$7,977,304 $1.38 29
2023 Q3 2,476,816 $2,575,547 +$96,462 $1.04 20
2023 Q2 2,329,087 $3,585,975 +$1,483,101 $1.54 21
2023 Q1 1,366,256 $1,775,782 +$205,068 $1.30 16
2022 Q4 1,208,609 $2,791,095 +$42,782 $2.31 16
2022 Q3 1,200,438 $2,422,000 -$2,883,379 $2.02 15
2022 Q2 2,356,498 $5,502,000 +$643,997 $2.26 14
2022 Q1 2,049,195 $7,019,000 +$917,618 $3.38 13
2021 Q4 1,777,567 $7,803,000 -$314,061 $4.39 12
2021 Q3 1,772,756 $12,191,000 +$12,191,000 $6.88 11